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approach merits further consideration and trial. Further- 
more, I believe combined carotid endarterectomy and 
coronary artery bypass grafting should be performed on a 
wider basis to determine potential risks and benefits in 
various subsets of patients to facilitate improved patient 
selection. 
Pat O. Daily, MD 
8010 Frost St. 
San Diego, CA 92123 
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Truncus arteriosus repair: Influence of techniques 
of right ventricular outflow tract reconstruction 
To the Editor: 
I was pleased to read the recently published article by 
Lacour-Gayet and associates I regarding truncus arterio- 
sus. The implications of different technical approaches 
used for right ventricular-pulmonary rtery outflow re- 
constructions on the immediate midterm, and long-term 
results are widely known. In this study, the authors used 
different types of conduits and a direct anastomosis to 
establish right ventricular-pulm0nary tery continuity. In 
five patients, a fresh autologous pericardial valved conduit 
was used, manufactured according to the description 
published by my colleague Schlichter and me. 2-4 It is not 
surprising to us that 100% of survivors in whom this 
technique was used did not require conduit replacement 
in more than 6 years of follow-up. In our experience 4' 5 in 
more than 50 patients followed up for 1 to 10.4 years 
(median 5 years), the conduit implant's freedom from 
reoperation was 90% at 5 years and 100% for those that 
measured more than 16 mm at the time of implantation. It 
is hard to believe that the 40% immediate mortality in two 
of five patients treated by this technique was purely 
related to the pericardial valved conduit and to severe 
pulmonary regurgitation. Both patients who died had 
interrupted aortic arch, one of whom was 2 days of age at 
the time of repair, and young age under 30 days is 
recognized by the authors as a risk factor. In addition, the 
diagnosis of severe pulmonary regurgitation i  the re- 
ported two patients is surprising, because we have not 
registered any case of moderate or severe postoperative 
pulmonary regurgitation during the immediate postoper- 
ative period• Furthermore, no considerations are made 
with respect o possible technical problems during tailor- 
ing of the conduit. To achieve success, the constructor 
must be extremely careful and follow all the steps pre- 
• 9 3 cisely, as they were described.-' 
We continue to believe that the autologous pericardial 
valved conduit is an effective, cheap, and highly successful 
option for the Rastelli repair or even the Ross procedure 
when no previous pericardial adhesions are present. We 
concur with the authors' observation on the advantageous 
capability of the autologous pericardial valved conduit o 
grow with time. 
Guillermo O. A. Kreutzer, MD 
Chief Division of Cardiac Surgery 
Hospital de Ni~os 
Buenos Aires, Argentina 
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Controlled limb reperfusion in patients with 
severe limb ischemia 
To the Editor: 
We read with great interest he recent article by Bey- 
ersdorf and associates 1 on limb reperfusion in the April 
1996 issue of the Journal. We congratulate hem on their 
excellent results with controlled limb reperfusion in pa- 
tients having severe limb ischemia. 
A factor that weakens this study, however, is the 
complete lack of perioperative serum myoglobin data. 
The postoperative effect of residual hypermyoglobinemia 
after controlled limb reperfusion on renal tubular func- 
tion is not clarified. In patients treated by uncontrolled 
normal blood reperfusion we usually see mild increases in 
serum potassium levels, without rhythm disturbances, but 
marked increases in serum creatine kinase and myoglobin 
values associated with postoperative r nal failure, which 
necessitate repeated hemodialysis. Although the authors 
noted massive washout of creatine kinase (20,414 _+ 7,710 
U/L), which indicates the presence of rhabdomyolysis, 
they never saw renal dysfunction requiring hemodialysis in
survivors. It was not possible to determine whether their 
different reperfusion technique might have affected post- 
operative renal tubular function. 
Their technique for controlled limb reperfusion was 
easily applied. However, this technique has a potential 
disadvantage in severely ill patients, because all effluent 
returns to the patient by way of the femoral vein. 
Yuzum Sakakibara, MD 
Toshio Mitsui, MD 
Department of Surgery 
The University of Tsukuba 
Tsukuba-City Ibaraki, Japa n 
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Reply to the Editor." 
My colleagues and I thank Drs. Sakakibara nd Mitsui 
for their interest in our work and for raising the important 
question of the effluent return to the systemic irculation. 
Undoubtedly, the venous effluent of limbs reperfused 
after several hours of complete ischemia contains greater 
amounts of myoglobin, free hemoglobin, creatine kinase, 
and potassium than do control limbs. After complete 
ischemia, this has been shown in experimental 1 and 
clinical 2studies. To a lesser degree, this increase was also 
measurable after revascularization for incomplete isch- 
emia. 3
These components in the venous effluent are a conse- 
quence of the severe local damage of skeletal muscle 
(rhabdomyolysis, edema) and are the cause for systemic 
complications (hyperkalemia, myoglobinemia, cute renal 
failure, acidosis, multiorgan failure, and death) following 
revascularization after prolonged periods of  limb isch- 
emia. 
Our limb reperfusion strategy has been developed to 
decrease the skeletal muscle reperfusion injury after re- 
vascularizations for prolonged ischemia. Less local dam- 
age will result in reduced concentrations of potassium, 
creatine kinase, and hydrogen ions in the venous effluent, 
which could be demonstrated in an experimental study. 1
Nevertheless, the venous effluent, even after controlled 
limb reperfusion, still contains ignificant amounts of end 
products of the rhabdomyolysis, which can only be pre- 
vented from entering the systemic irculation by discard- 
ing the venous effluent. Simply discarding the venous 
effluent is not possible because of the large amount of 
blood that would be lost. The same is true for any filtering 
process. The only possibility is to separately cannulate the 
femoral arteries and veins and use an extracorporeal 
circulation including oxygenat0r and roller pumps. This 
approach was recently described by Vogt and coworkers 2 
from the Zfirich group in a patient with complete ischemia 
for 24 hours. 
The concentrations of myoglobin, potassium, and crea- 
tine kinase in the venous effluent are related to the 
severity of ischemia (complete/incomplete) (1/3) and the 
duration of ischemia (2/4). The more severe the ischemic 
insult, the more pronounced is the reperfusion damage, 
resulting in higher concentrations in the venous effluent. 
In our three-center study, 4 we were able to reduce the 
concentrations of myoglobin, potassium, and creatine 
kinase to a level that did not produce systemic hyperka- 
lemia or renal failure. However, Vogt and coworkers 2 
have used a complete xtracorporeal circuit (including an 
oxygenator) for a patient with complete ischemia for 24 
hours and achieved excellent results with this approach. In 
patients with complete ischemia exceeding 24 to 36 hours, 
it might very well be necessary to discard the venous 
effluent and use an extracorporeal circuit to prevent 
severe systemic side effects. In our study with a mean 
ischemic time of 26 hours (range 6 to 39 hours), we did see 
systemic increases in potassium, creatine kinase, creati- 
nine, and blood urea nitrogen; however, this did not 
produce remote organ failure. Even though we did not 
measure myoglobin concentrations in our patients, the 
fact that none had severe renal failure shows that there 
was no major renal tubular dysfunction. 
Ideally, future refinements in the technique of con- 
trolled limb reperfusion will elucidate criteria, identify 
which patients will need controlled limb reperfusion with- 
out complete xtracorporeal circulation, and define those 
patients who need controlled reperfusion with venous 
effluent discardment. 
Friedhelm Beyersdorf, MD 
Department of Cardiovascular Surgery 
Albert-Ludwigs- Universitiit Freiburg 
79106 Freiburg, Germany 
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Failure of devices used for the closure of atrial 
septal defects 
To the Editor." 
I read with interest he report of Agarwal, Ghosh, and 
Mittal 1 on the surgical management of unsuccessful atrial 
septal defect (ASD) closures with the AngelWings device 
(Microventa Corp., White-Bear Lake, Minn.). These clo- 
sures were performed by me as a part of the International 
ASD Closure Trial, which is being organized by the 
University of Minnesota to evaluate the feasibility, safety, 
and efficacy of a new percutaneous device 2 developed at 
the University of Minnesota. Our preliminary clinical 
experience in the first 100 patients (including the six 
reported by Agarwa!, Ghosh, and Mittal 1) has been 
submitted for publication. The overall procedural success 
rate is 90%. We have learned a large number of lessons in 
the clinical use of this device from the more than 100 
patients who have undergone this procedure. 
The reason for emergency surgery for retrieval of errant 
devices has been the difficulty in retrieving the device, 
which is made of a nitinol alloy framework with a high 
tensile strength. Although we have demonstrated our 
ability to retrieve the device with snares in animal mod- 
els, a the stiff wire can potentially perforate cardiac ham- 
bers and systemic veins. The overriding concern in the 
clinical trials has been that of patient safety and hence the 
adoption of a policy of surgical removal of unsuccessfully 
deployed evices and closure of defects. We have concur- 
rently developed a system for retrieving these devices 
safely. Once this is made available to participating centers, 
